Analysed SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) News Sources
Solaris Secures EIA Technical Approval and Further Strengthens the Balance Sheet
09-04-2026
yahoo.com
All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy
26-03-2026
yahoo.com
Wall Street Analysts Believe SELLAS Life Sciences Group, Inc. (SLS) Could Rally 63.58%: Here's is How to Trade
26-03-2026
yahoo.com
Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run
22-03-2026
yahoo.com
SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths
20-03-2026
247wallst.com
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
19-03-2026
yahoo.com
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
17-03-2026
yahoo.com
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
12-03-2026
yahoo.com
What is the current price of SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ)?
The current price of SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) is $4.77.
SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) absolute price change since previous trading day?
The absolute price change of SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) since the previous trading day is $-0.28.
SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) percentage price change since previous trading day?
The percentage price change of SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) since the previous trading day is -5.5446%.
What is the most recent average sentiment score for SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ)?
The most recent average sentiment score for SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ)?
The most recent sentiment for SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ) is .
SEC-8K** Filing Available For SELLAS LIFE SCIENCES GROUP I (SLS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.